Streetbeat News

Regulatory

SABS

SAB Biotherapeutics has received FDA clearance for its IND application to proceed with a Phase 1 trial for SAB-142, a treatment for Type 1 Diabetes.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 11:16 am

AZO

IWM

LOW

M

NVDA

PANW

QQQ

SPY

TOL

URBN

VSAT

ZM

Wall Street is expected to open mostly flat as traders await Nvidia's earnings and several Fed speeches. Bitcoin surged above $71K on Ethereum ETF approval speculation. Key stocks in focus include Nvidia, Palo Alto Networks, Zoom Video Communications, Lowe's, AutoZone, Macy's, Toll Brothers, Viasat, and Urban Outfitters.

Portfolio Pulse from Shanthi Rexaline

May 21, 2024 | 11:14 am

CLSD

Clearside Biomedical has announced the publication of consensus guidelines for drug delivery via suprachoroidal space (SCS) injection in the peer-reviewed journal RETINA. An expert panel of ophthalmologists developed these guidelines, which support SCS injection as a safe and effective method for delivering retinal and choroidal therapeutics.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 11:13 am

NABL

N-able and MSPAlliance have partnered to assist Managed Service Providers (MSPs) in navigating cybersecurity compliance requirements. This collaboration aims to provide MSPs with the necessary tools and resources to meet regulatory standards and enhance their cybersecurity posture.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 11:12 am

BMY

The FDA has reassigned the Prescription Drug User Fee Act (PDUFA) date for Bristol Myers Squibb's subcutaneous formulation of Opdivo (Nivolumab) for all previously approved adult, solid tumor indications. The new goal date is December 29.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 11:01 am

PZG

The Bureau of Land Management (BLM) and the Oregon Department of Geology and Mineral Industries (DOGAMI) have agreed to a joint reclamation bond for the proposed Grassy Mountain Gold and Silver Mine. This development is significant for Paramount Gold Nevada Corp (PZG), which is involved in the project.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 11:01 am

ETHUSD

Ethereum futures open interest has reached a record $15.1 billion, driven by optimism about the potential approval of spot ETH ETFs in the U.S. Bloomberg analysts have increased the likelihood of approval from 25% to 75%, and the SEC has requested expedited filings from exchanges. Ethereum's price has surged by nearly 20% in the last 24 hours.

Portfolio Pulse from Benzinga Neuro

May 21, 2024 | 11:00 am

CTXR

Trading for CTXR was halted at 6:55:00 a.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 10:55 am

PSNY

Polestar shares are trading lower after the company acknowledged receiving a deficiency notice from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 10:44 am

LRMR

Larimar Therapeutics shares are trading higher after the company announced that the FDA removed the partial clinical hold previously placed on the nomlabofusp clinical program.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 10:33 am